-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Downgrades Amphastar Pharma to Equal-Weight, Lowers Price Target to $19

Benzinga·05/14/2026 12:37:20
Listen to the news
Wells Fargo analyst Benjamin Burnett downgrades Amphastar Pharma (NASDAQ:AMPH) from Overweight to Equal-Weight and lowers the price target from $30 to $19.